EXOSOME POWERED Exosome solutions for early detection and treatment of cancer DISRUPTIVE TECHNOLOGY Proprietary exosome and SubB2M technologies PRODUCTS IN MARKET Exosome research tools and bladder cancer test generating revenues PIPELINE Differentiated, multi-stage exosome research tool, diagnostic and therapeutic pipeline for cancer CLINICAL DATA Data showing superior exosome isolation, accurate cancer detection and in vitro cancer killing activity PARTNERING FOR GROWTH Global partners for sales of EXO-NET and development of exosome diagnostics to accelerate growth INOVIQ is pioneering next-generation diagnostics and therapeutics to enhance patient outcomes for cancer and other diseases. The product portfolio includes products in-market for exosome research 2 INOVIQ Limited CEO’s Report INOVIQ is pioneering next-generation diagnostics and therapeutics to enhance patient outcomes for cancer and other diseases. and bladder cancer diagnosis, clinical-stage cancer diagnostics for detection and monitoring of breast and ovarian cancers, and an early-stage exosome therapeutic for solid tumours. EXOSOME CAPTURE TOOLS IN-MARKET, GENERATING REVENUE AND GLOBAL DISTRIBUTION INOVIQ’s best-in-class exosome capture technology for exosome biomarker discovery and diagnostics is now commercially available worldwide. The global joint marketing agreement with leading life sciences company Promega Corporation was expanded to a global supply and distribution agreement in April 2024 to market, distribute and sell EXONET worldwide. INOVIQ received its first order from Promega under the new agreement in June 2024, with the partnership expected to be a major driver of EXO-NET revenues. The exosome research tool portfolio was expanded with the development and validation of NEURO-NET™ for isolation and analysis of brain-derived exosomes that are present in blood of Alzheimer’s Disease and Parkinson’s Disease patients. Exosomes cross the “blood-brain barrier” and provide a “fingerprint” of the health or disease status of the brain for use in brain cancer, neuropsychiatric disorders and neurodegenerative diseases. NEURO-NET expands INOVIQ’s exosome capabilities and partnering opportunities to develop novel diagnostics for neurological conditions.
RkJQdWJsaXNoZXIy MjE2NDg3